5-Amino-1MQ in Australia: NNMT Inhibitor Research Guide

5-Amino-1MQ (5-amino-1-methylquinolinium) is a small-molecule inhibitor of nicotinamide N-methyltransferase (NNMT), an enzyme found primarily in adipose (fat) tissue and the liver. Unlike most research peptides, which are chains of amino acids, 5-Amino-1MQ is a synthetic organic compound. Despite not being a peptide in the traditional sense, it is commonly categorised alongside research peptides due to its use in metabolic biology research and its availability from research peptide suppliers.

NNMT catalyses the transfer of a methyl group from S-adenosylmethionine (SAM) to nicotinamide, producing 1-methylnicotinamide. By consuming SAM, NNMT activity reduces the availability of methyl groups for other cellular methylation reactions and lowers NAD+ precursor availability. 5-Amino-1MQ competitively inhibits this process.

NNMT is significantly overexpressed in the adipose tissue of obese individuals and in obesity-associated metabolic disease. Research has established NNMT as a regulator of adipocyte energy metabolism, with high NNMT activity associated with reduced energy expenditure in fat cells.

Preclinical data on NNMT inhibition shows several metabolically relevant effects in rodent models:

• Increased NAD+ levels, by reducing nicotinamide consumption, NNMT inhibition raises intracellular NAD+, activating sirtuin pathways (SIRT1, SIRT3) and AMPK
• Enhanced adipocyte energy expenditure, treated adipocytes show increased mitochondrial activity and fat oxidation in in-vitro models
• Reduced adipogenesis, inhibition of NNMT in precursor adipocyte cells reduces differentiation into mature fat cells in preclinical studies
• Body weight and fat mass reduction, diet-induced obese mice treated with NNMT inhibitors demonstrated reduced body weight and fat mass without significant changes in food intake, suggesting a thermogenic/metabolic mechanism rather than appetite suppression

The key distinction from GLP-1-based weight loss compounds is mechanism: retatrutide and tirzepatide primarily reduce food intake via appetite suppression; NNMT inhibitors act on energy expenditure within adipose tissue itself.

A common research question is how 5-Amino-1MQ compares or complements GLP-1-based compounds. The mechanisms are fundamentally different:

• GLP-1 agonists (retatrutide, tirzepatide, semaglutide), act centrally on hypothalamic receptors to reduce appetite and food intake; also affect insulin secretion and glucose metabolism
• 5-Amino-1MQ / NNMT inhibitors, act peripherally in adipose tissue to increase energy expenditure; no direct effect on appetite signalling

This mechanistic complementarity has led to research interest in combining NNMT inhibitors with GLP-1-based compounds, targeting both energy intake and energy expenditure simultaneously. Human data on such combinations does not yet exist, but the preclinical rationale is established.

For researchers studying 5-Amino-1MQ alongside GLP-1 compounds, see the Retatrutide research guide and GLP-1 research guide.

5-Amino-1MQ sits at the intersection of NNMT inhibition and NAD+ biology, a field that has attracted considerable research interest following work on sirtuins, PARP enzymes, and longevity pathways. By reducing nicotinamide consumption by NNMT, the compound increases availability of NAD+ precursors and raises cellular NAD+ levels.

This mechanistic connection links 5-Amino-1MQ research to the broader NAD+ supplementation literature (NMN, NR) but with an important distinction: rather than supplementing NAD+ precursors from outside the cell, NNMT inhibition prevents their depletion within the cell, a complementary approach to the same endpoint.

For researchers also studying NAD+ biology, see the NAD+ research guide.

5-Amino-1MQ is available from Australian research compound suppliers. Unlike lyophilised peptides, 5-Amino-1MQ is typically supplied as a powder at higher mass quantities (milligrams to grams), reflecting its status as a small organic molecule rather than a peptide.

OzPeps stocks research-grade 5-Amino-1MQ with fast Australia-wide shipping. View 5-Amino-1MQ stock and pricing →

All 5-Amino-1MQ products from OzPeps are supplied strictly for in-vitro laboratory and research purposes. Not TGA-approved. Not for human or animal consumption. Researchers are responsible for all applicable regulatory compliance.